Post-traumatic stress disorder (PTSD) is moderately heritable, with estimates ranging from 30 to 70%.
1 However, most of the genetic variation accounting for this heritability has yet to be identified, and the majority of molecular studies to date on PTSD have been candidate gene designs. 2 Only one genome wide association study of PTSD has been published. In a sample of white nonHispanic trauma-exposed veterans and their spouses/partners with and without PTSD, Logue and colleagues 3 found that one single nucleotide polymorphism (SNP; rs8042149) in the retinoidrelated orphan receptor alpha gene (RORA) reached genome-wide significance. RORA has been implicated, in part, in protecting brain cells from the damaging effects of injury, stress and disease, 3 and it is possible that individuals with the variation in RORA may be at increased risk for developing PTSD due to deficits in initiating neuroprotective processes after trauma. We sought to provide supporting evidence for the genetic association between RORA*rs8042149 and PTSD using data from the 2004 Florida hurricanes study.
The 2004 Florida hurricanes study is based on a stressorexposed epidemiologic sample of adults who were living in Florida counties that were declared disaster areas following Hurricanes: Charley, Francis, Ivan or Jeanne. Participants were selected via random digit-dial procedures, and they were interviewed via telephone about hurricane exposure, social support and posthurricane PTSD symptoms. Participants also were asked to provide saliva samples for genotyping (for details on response rate and associations of participation in the study, see 4, 5 ) . In this sample, we tested the most significant variant in RORA reported by Logue et al. 3 by examining the association between rs8042129 and posthurricane DSM-IV PTSD symptom count (range 0-17, M ¼ 1.6, s.d. ¼ 2.6). We chose the symptom count as our outcome given the low prevalence of full diagnostic PTSD (2.7%). To reduce potential bias of population stratification, the sample for this report consisted of the self-identified European-American subsample of adults exposed to the 2004 Florida hurricanes who returned a DNA sample that yielded valid data for rs8042129 (n ¼ 551; 65% female). RORA rs8042129 genotype frequencies were in Harvey-Weinberg equilibrium, and genotype frequencies were as follows: G/G (n ¼ 159, 28.9%), G/T (n ¼ 280, 50.8%) and T/T (n ¼ 112, 20.3%). A linear regression analysis predicting posthurricane PTSD symptoms was conducted, controlling for covariates that emerged as significant predictors of PTSD in previous analyses (sex, age, hurricane exposure, social support; for example, Amstadter et al.) . 6 The overall model was significant, F(5,538) ¼ 9.75, Po0.001. Furthermore, the RORA rs8042149 SNP accounted for significant variance in PTSD symptom severity, b ¼ À 0.09, t ¼ À 2.20, P ¼ 0.028. Specifically, the G allele was associated with higher PTSD symptoms after the hurricane.
In summary, we were able to support the association between rs8042149 and PTSD symptom count in a sample of adults who were exposed to an acute stressor. As demonstrated by Logue et al., 3 we found a main effect of rs8042149 on post-trauma distress, with the G allele being associated with higher PTSD symptom levels. Similar to Logue et al., 3 we found this association in a European-American sample. However, whereas Logue et al. 3 observed this relation in a sample of veterans and their spouses/ partners with a diverse history of traumatic experiences, we extended this finding to a sample of individuals exposed to a recent natural disaster. A major strength of replicating this finding with a disaster-exposed epidemiologic sample is that the possible effects of a gene-environment correlation were reduced because exposure to non-assaultive trauma (for example, natural disasters) has been found to have lower heritability estimates than exposure to assaultive traumas.
1 One notable limitation of the present study is the low prevalence of PTSD, and low overall average PTSD symptom count, suggesting the need for replication in more severely affected samples.
This study adds to a growing body of research that suggests that polymorphisms of the RORA gene are associated with risk for various forms of psychopathology, including PTSD, autism, ADHD, bipolar disorder and depression. [7] [8] [9] [10] Further research is needed to understand better how RORA polymorphisms may contribute to the development of psychopathology. RORA is a member of the NR1 subfamily of nuclear hormone receptors, and the protein encoded by the gene is implicated in a number of processes, including brain development, neuroprotection and the regulation of circadian rhythms and steroid hormones. 3 Although understanding of RORA's role in PTSD in particular is limited, it is possible that deficits in these functions may exacerbate the deleterious effects of trauma on the brain. Future research should examine how genetic variation in RORA may translate into differential functional and structural outcomes that may put individuals at risk for PTSD.
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The authors declare no conflict of interest. Smoking dependence is a complex trait that is significantly influenced by genetics, with an estimated heritability of 0.56. Previous genome-wide association meta-analysis revealed that rs6474412, located about 2.1 kb from the 5 0 end of CHRNB3, is significantly associated with the number of cigarettes smoked per day.
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1 In addition, nominal associations of several variants in or near the CHRNB3 gene with smoking behavior have been reported.
2-5 However, almost all subjects used in these studies were of European ancestry. Given the demonstrated differences across ethnicities with respect to genetics, physiological processes and behavior underlying nicotine dependence (ND), [6] [7] [8] [9] [10] [11] it is of great interest to examine whether this gene also is associated with ND in smokers of other ancestries. To attack this issue, we performed a meta-analysis of variants in CHRNB3 in relation to ND by combining data from the studies of subjects of different ethnicities.
Techniques for ascertainment, diagnostic assessments, genotyping, quality control and analysis are detailed elsewhere.
12-14
The four samples included in this study can be described briefly as follows. This study involves three samples: the Collaborative Study on the Genetics of Alcoholism, the Family Study of Cocaine Dependence (FSCD) and the Collaborative Genetic Study of Nicotine Dependence. The FTND score was available for all case subjects; some of them were addicted to cocaine, alcohol, marijuana, opiate and/or other substances as well as tobacco. To minimize the effects of other addictive phenotypes on the association results of CHRNB3 variants with ND, all the phenotypes were included as covariates in our association analysis. For the FSCD sample, only one subject from each family was used. Together, a total of 2428 subjects with EA ancestry and 1136 with AA ancestry were included. (3) A Genome Wide Scan of Lung Cancer and Smoking (CGEMS):
13 This study involves two samples. The first contains about 2000 patients with newly diagnosed lung cancer and around 2000 age-, sex-and region-matched controls, all recruited from the Lombardy region of Italy. 15 The second sample contains about 850 lung cancer patients and about 850 age-and sexmatched controls.
16 Almost all subjects of this study were assessed by a variety of smoking measures, including FTND score, and were of European ancestry. (4) Korea Association Resource (KARE) study:
14 All subjects in this study were recruited from two areas, Ansung and Ansan, in South Korea. After appropriate quality control and filtering, 8842 individual samples (4183 men and 4659 women) were eligible. Because no FTND score was available for these smokers, the ND phenotype was analyzed as an ordinal trait with five categories (1-5), as we did previously on this sample 17, 18 according to the number of cigarettes smoked per day: non-smoking, o10 cigarettes/day, 11-20 cigarettes/day, 21-30 cigarettes/day, and431 cigarettes/ day, respectively. All studies were conducted under the appropriate ethical approvals, and all subjects provided written informed consent.
Except for the MSTCC DNA samples, which were genotyped with TaqMan assay in a 384-well microplate format, genotyping results for the SAGE and CGEMS samples came from the National Institutes of Health database of Genotypes and Phenotypes. Except for Single Nucleotide Polymorphism (SNP) rs6474412 selected from the reported study, 1 other six SNPs were selected according to our preliminary association analysis results of SAGE data. Quality control was performed in each sample separately with the goal of removing those individuals with sex anomalies, low call rate or first-or second-degree relatedness. For those nongenotyped SNPs in the original SAGE, CGEMS and KARE data sets, we conducted imputation using MaCH 19 and IMPUTE (v2). 20 To make the SNPs consistent across different samples, we imputed rs6474412 for SAGE, 6 SNPs except rs10958725 for CGEMS and all 7 SNPs for KARE using the 1000 Genome EUR v2 (2010-11 release) for samples of European origin, the 1000 Genome AFR v2 (2010-11 release) for samples of African origin, and the HapMap Phase II CHB þ JPT for samples of Asian origin as reference panels.
Following appropriate quality control and imputation, we conducted a meta-analysis of six samples of African, European or Asian ancestry. For each sample, association analysis was performed on smokers only using a linear regression model by regressing FTND scores for the MSTCC, SAGE and CGEMS samples and indexed CPD for the KARE sample on age, sex, SNP allele dosage and other cohort-specific covariates in PLINK, 21 and all non-smokers were excluded from the regression analysis. Supplementary Table 1 shows detailed information on each sample, including descriptions, the covariates included in the regression model, sample size of original study, and sample size of smokers used in the current analysis and their corresponding ND measure and related ND statistics. Supplementary Table 2 presents detailed association analysis results of each SNP among all samples, which include allele frequency for positive effect allele, beta value, and P value. Fixed-effects meta-analysis was conducted in METAL 22 using the inverse variance-weighted method, which has the advantage of calculating the effect size and corresponding standard error for each SNP of interest. Heterogeneity within each ethnic sample(s) or among different ethnic samples was assessed with I 2 in METAL, which measures the degree of inconsistency among the results from different samples. 23 As shown in Table 1 , our meta-analysis of the association of CHRNB3 variants with ND in the three ethnic populations revealed the following main findings. (A) All alleles with positive effects for the seven SNPs in CHRNB3 are the same in the three populations,
